Effect of a proton pump inhibitor (omeprazole, Prilosec) on imatinib mesylate (Gleevec) pharmacokinetics in healthy volunteers (CSTI571BUS258)

Trial Profile

Effect of a proton pump inhibitor (omeprazole, Prilosec) on imatinib mesylate (Gleevec) pharmacokinetics in healthy volunteers (CSTI571BUS258)

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Imatinib (Primary) ; Omeprazole
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic myeloid leukaemia; Dermatofibrosarcoma; Gastrointestinal stromal tumours; Malignant melanoma; Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Sep 2009 Actual end date (1 Aug 2009) added as reported by ClinicalTrials.gov
    • 09 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 15 Feb 2008 The expected completion date for this trial is now 1 Dec 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top